These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28561935)

  • 1. Clinicopathological characteristics of KIT and protein kinase C-δ expression in adenoid cystic carcinoma: comparison with chromophobe renal cell carcinoma and gastrointestinal stromal tumour.
    Park CK; Kim WK; Kim H
    Histopathology; 2017 Oct; 71(4):529-542. PubMed ID: 28561935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DOG1 and PKC-θ are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors.
    Kang GH; Srivastava A; Kim YE; Park HJ; Park CK; Sohn TS; Kim S; Kang DY; Kim KM
    Mod Pathol; 2011 Jun; 24(6):866-75. PubMed ID: 21358619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
    Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
    J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained Mutant KIT Activation in the Golgi Complex Is Mediated by PKC-θ in Gastrointestinal Stromal Tumors.
    Kim WK; Yun S; Park CK; Bauer S; Kim J; Lee MG; Kim H
    Clin Cancer Res; 2017 Feb; 23(3):845-856. PubMed ID: 27440273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours.
    Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM
    Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases.
    Kim KH; Nelson SD; Kim DH; Choi KU; Kim SJ; Min KW; Jang KS; Paik SS; Oh YH; Chae SW; Sohn JH; Kim HJ; Cho YK; Kim BI; Park DI; Sohn CI; Oh S; Choi SH; Choi YJ; Woo HY; Park YL; Park SJ; Lee SH; Ryu S; DO SI; Kang G; Kim K; Cho YH; Pyo JS
    Anticancer Res; 2012 Mar; 32(3):923-37. PubMed ID: 22399613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
    Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
    J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
    Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
    Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of alpha-smooth muscle actin and c-kit in the differential diagnosis of adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma.
    Epivatianos A; Poulopoulos A; Dimitrakopoulos I; Andreadis D; Nomikos A; Vlahou S; Papazoglou G; Barbatis C
    Oral Oncol; 2007 Jan; 43(1):67-76. PubMed ID: 16807072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis.
    Quattrone A; Dewaele B; Wozniak A; Bauters M; Vanspauwen V; Floris G; Schöffski P; Chibon F; Coindre JM; Sciot R; Debiec-Rychter M
    J Pathol; 2012 Dec; 228(4):565-74. PubMed ID: 22786615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance.
    Zhu MJ; Ou WB; Fletcher CD; Cohen PS; Demetri GD; Fletcher JA
    Oncogene; 2007 Sep; 26(44):6386-95. PubMed ID: 17452978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
    Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
    Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of c-KIT (CD117) expression in renal cell carcinoma.
    Ahmed EA; Youssif ME
    J Egypt Natl Canc Inst; 2009 Jun; 21(2):121-32. PubMed ID: 21057563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.
    Jang BG; Lee HE; Kim WH
    Virchows Arch; 2015 Oct; 467(4):393-403. PubMed ID: 26243012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations.
    Wetterskog D; Wilkerson PM; Rodrigues DN; Lambros MB; Fritchie K; Andersson MK; Natrajan R; Gauthier A; Di Palma S; Shousha S; Gatalica Z; Töpfer C; Vukovic V; A'Hern R; Weigelt B; Vincent-Salomon A; Stenman G; Rubin BP; Reis-Filho JS
    Histopathology; 2013 Mar; 62(4):543-50. PubMed ID: 23398044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C-δ-mediated recycling of active KIT in colon cancer.
    Park M; Kim WK; Song M; Park M; Kim H; Nam HJ; Baek SH; Kim H
    Clin Cancer Res; 2013 Sep; 19(18):4961-71. PubMed ID: 23881925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
    Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
    Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of expression of molecular markers in adenoid cystic cancer of the salivary glands compared with lymph node metastasis: a retrospective study.
    Lee SK; Kwon MS; Lee YS; Choi SH; Kim SY; Cho KJ; Nam SY
    World J Surg Oncol; 2012 Dec; 10():266. PubMed ID: 23231994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGFRalpha- and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features.
    Pauls K; Merkelbach-Bruse S; Thal D; Büttner R; Wardelmann E
    Histopathology; 2005 Feb; 46(2):166-75. PubMed ID: 15693889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy and c-Kit mutation in gastrointestinal stromal tumors.
    Lee JH; Zhang X; Jung WY; Chae YS; Park JJ; Kim I
    World J Gastroenterol; 2004 Dec; 10(23):3475-9. PubMed ID: 15526368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.